r.rotation.to⌕ Search stocks, people, sectors
Request a free account

Follow the people · Insider

ES

Eli Samaha

Insider · 10% owner · tbph

Eli Samaha files insider transactions with the SEC as a 10% owner of Theravance Biopharma (tbph). We hold 5 disclosed purchases and sales filed since 11 August 2021, 5 of them in the last 90 days.

  • Files fortbph
  • Disclosed buys and sells5 in all, 5 in the last 90 days
  • Last disclosure8 July 2026

Positions held

7 posts we hold — a term names its own dates; a run of filings only says when they filed
  • Filed 7 August 2024 — 7 July 202610% owner · Theravance Biopharma (tbph)6 Form 4 lines · source: SEC Form 4
  • Filed 9 August 2021 — 1 July 2026Director · Stagwell (STGW)28 Form 4 lines · source: SEC Form 4
  • Filed 31 May 2024 — 10 June 202410% owner · Synovus Financial (SNV PR E)7 Form 4 lines · source: SEC Form 4
  • Filed 1 May 2024 — 1 May 202410% owner · Theravance Biopharma (TBPH)2 Form 4 lines · source: SEC Form 4
  • Filed 22 September 2023 — 20 October 202310% owner · Synovus Financial (SNV PRE)11 Form 4 lines · source: SEC Form 4
  • Filed 19 September 2023 — 21 September 202310% owner · Synovus Financial (SNV PrE)3 Form 4 lines · source: SEC Form 4
  • Filed 14 April 2022 — 29 December 202210% owner · Pfsweb (PFSW)13 Form 4 lines · source: SEC Form 4

Everything they disclosed

70 entries, newest first — one per disclosure report, one per Form 4 line

Positions come from the unitedstates/congress-legislators roster, the Office of Government Ethics and the SEC’s Form 4 index. Every disclosed line names its own source and links the document the government published; we print what the filing says and never a price we did not read from it. Headlines and links come from the GDELT Global Knowledge Graph — the story stays with the publisher. The portrait, where we have one, is the public-domain Congressional Bioguide photograph.